These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22891510)

  • 1. Patient and family issues regarding genetic testing for cystic fibrosis: a review of prenatal carrier testing and newborn screening.
    Sparbel KJ; Tluczek A
    Annu Rev Nurs Res; 2011; 29():303-29. PubMed ID: 22891510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Status of Genetic Diagnosis Laboratories and Frequency of Genetic Variants Associated with Cystic Fibrosis through a Newborn-Screening Program in Turkey.
    Bozdogan ST; Mujde C; Boga I; Sonmezler O; Hanta A; Rencuzogullari C; Ozcan D; Altintas DU; Bisgin A
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33572515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
    Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
    Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
    Sands D; Zybert K; Mierzejewska E; Ołtarzewski M
    Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons learned from 20 years of newborn screening for cystic fibrosis.
    Massie RJ; Curnow L; Glazner J; Armstrong DS; Francis I
    Med J Aust; 2012 Jan; 196(1):67-70. PubMed ID: 22256939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CFTR variant profile of Hispanic patients with cystic fibrosis: Impact on access to effective screening, diagnosis, and personalized medicine.
    Januska MN; Marx L; Walker PA; Berdella MN; Langfelder-Schwind E
    J Genet Couns; 2020 Aug; 29(4):607-615. PubMed ID: 32227567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of newborn screening for cystic fibrosis in Norway. Results from the first three years.
    Lundman E; Gaup HJ; Bakkeheim E; Olafsdottir EJ; Rootwelt T; Storrøsten OT; Pettersen RD
    J Cyst Fibros; 2016 May; 15(3):318-24. PubMed ID: 26795017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe lung disease in children with cystic fibrosis missed in newborn screening.
    Baldwin K; Barker EM; Carayannopoulos M; Farrell PM; Zanni R; Scanlin TF
    Pediatr Pulmonol; 2024 Jan; 59(1):163-168. PubMed ID: 37888495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of newborn screening for cystic fibrosis in Europe.
    Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
    J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in cystic fibrosis newborn screening algorithms in the United States.
    Rehani MR; Marcus MS; Harris AB; Farrell PM; Ren CL
    Pediatr Pulmonol; 2023 Mar; 58(3):927-933. PubMed ID: 36507555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses.
    Sosnay PR; Salinas DB; White TB; Ren CL; Farrell PM; Raraigh KS; Girodon E; Castellani C
    J Pediatr; 2017 Feb; 181S():S27-S32.e1. PubMed ID: 28129809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in clinical condition and genotype at time of diagnosis of cystic fibrosis by newborn screening or by symptoms.
    Vernooij-van Langen AM; Gerzon FL; Loeber JG; Dompeling E; Dankert-Roelse JE
    Mol Genet Metab; 2014; 113(1-2):100-4. PubMed ID: 25077434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Phenotypes of Cystic Fibrosis Carriers.
    Polgreen PM; Comellas AP
    Annu Rev Med; 2022 Jan; 73():563-574. PubMed ID: 35084992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of Cystic Fibrosis in Nonscreened Populations.
    Sosnay PR; White TB; Farrell PM; Ren CL; Derichs N; Howenstine MS; Nick JA; De Boeck K
    J Pediatr; 2017 Feb; 181S():S52-S57.e2. PubMed ID: 28129813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
    Levy H; Nugent M; Schneck K; Stachiw-Hietpas D; Laxova A; Lakser O; Rock M; Dahmer MK; Biller J; Nasr SZ; Baker M; McColley SA; Simpson P; Farrell PM
    Clin Genet; 2016 May; 89(5):539-49. PubMed ID: 26671754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis newborn screening.
    Com G
    J Ark Med Soc; 2010 Mar; 106(9):210-2. PubMed ID: 20337169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging issues in cystic fibrosis newborn screening.
    Castellani C; Massie J
    Curr Opin Pulm Med; 2010 Nov; 16(6):584-90. PubMed ID: 20814308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels?
    Scotet V; Audrézet MP; Roussey M; Rault G; Dirou-Prigent A; Journel H; Moisan-Petit V; Storni V; Férec C
    Pediatrics; 2006 Nov; 118(5):e1523-9. PubMed ID: 17015492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncommon clinical presentation of cystic fibrosis in a patient homozygous for a rare CFTR mutation: a case report.
    Jaworska J; Marach-Mocarska A; Sands D
    BMC Pediatr; 2020 Feb; 20(1):90. PubMed ID: 32103733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal screening for cystic fibrosis: past, present and future.
    Richards CS; Grody WW
    Expert Rev Mol Diagn; 2004 Jan; 4(1):49-62. PubMed ID: 14711349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.